Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.

Clift AK. et al, (2023), BMJ, 381

Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in England

Gannon MR. et al, (2023), Cancer Epidemiology, 83

The Association Between Survival and Receipt of Post-mastectomy Radiotherapy According to Age at Diagnosis Among Women With Early Invasive Breast Cancer: A Population-Based Cohort Study.

Miller K. et al, (2023), Clin Oncol (R Coll Radiol), 35, e265 - e277

Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.

Holt F. et al, (2023), Int J Radiat Oncol Biol Phys

Cytotoxic Chemotherapy for Pancreatic Adenocarcinoma in England 2010-2017: Survival Outcomes.

Wang Z. et al, (2023), Clin Oncol (R Coll Radiol)

Anthracycline and taxane containing chemotherapy for early-stage operable breast cancer: meta-analyses of 100,000 women in 86 randomised trials

Taylor CAROLYN. et al, (2023), The Lancet

Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia.

Clements K. et al, (2022), BMJ Open, 12

The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England.

Gathani T. et al, (2022), Br J Cancer, 1 - 3

The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)-results from the UK Sloane Project.

Shaaban AM. et al, (2022), British journal of cancer

Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis.

Bundred JR. et al, (2022), BMJ, 378

Width of excision margins after breast conserving surgery for invasive breast cancer and distant recurrence and survival.

Bundred NJ. et al, (2022), BMJ, 378

Palliative chemotherapy for breast cancer: A population-based cohort study of emergency hospital admissions and place of death.

Bright CJ. et al, (2022), Eur J Cancer Care (Engl), 31

Change in the Use of Fractionation in Radiotherapy Used for Early Breast Cancer at the Start of the COVID-19 Pandemic: A Population-Based Cohort Study of Older Women in England and Wales.

Gannon MR. et al, (2022), Clin Oncol (R Coll Radiol)

Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.

Kerr AJ. et al, (2022), Cancer Treat Rev, 105

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results.

Bundred N. et al, (2022), Clin Cancer Res, 28, 1323 - 1334

Development and validation of clinical prediction models for breast cancer incidence and mortality: a protocol for a dual cohort study.

Clift AK. et al, (2022), BMJ Open, 12

Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2022), Lancet Oncol, 23, 382 - 392

The association between guideline adherence, age and overall survival among women with non-metastatic breast cancer: A systematic review.

Miller K. et al, (2022), Cancer Treat Rev, 104

The current status of risk-stratified breast screening.

Clift AK. et al, (2022), Br J Cancer, 126, 533 - 550

Impact of the COVID-19 pandemic on breast cancer referrals and diagnoses in 2020 and 2021: a population-based study in England.

Gathani T. et al, (2022), Br J Surg, 109, e29 - e30

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?